GlassScriptPhysician profile
William O Richards
NPI 1548368491
$12,558.68
in general payments reported to CMS, 2019-2025
22 companies · $2,772 in 2025
The $2,772 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,967 · 2020: $151 · 2021: $417 · 2022: $989 · 2023: $1,548 · 2024: $2,715 · 2025: $2,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,323 · Food and Beverage: $2,647 · Education: $48.58 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,322.79 |
| Food and Beverage | $2,647.01 |
| Education | $48.58 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,121.77 | 2019-2025 | Da Vinci Surgical System |
| Histosonics, INC. | $2,558.01 | 2024-2025 | |
| Tela Bio, INC. | $2,293.64 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Davol INC. | $349.28 | 2023-2025 | Phasix Mesh |
| Standard Bariatrics, INC. | $221.86 | 2022 | |
| Baxter Healthcare | $149.42 | 2021-2025 | Tisseel, Seprafilm |
| Teleflex LLC | $130.72 | 2023-2025 | Titan Sgs Bailout Chuck, Titan Sgs Standard Gastric Stapler |
| Ethicon US, LLC | $121.47 | 2019-2022 | |
| Trevena, INC. | $81.37 | 2021-2023 | Olinvyk |
| Ambu INC. | $79.53 | 2022 | |
| Acell, INC. | $67.57 | 2019 | |
| Medtronic, INC. | $67.22 | 2023-2025 | Maxtack, Absorbatack, Sonicision |
| Lucid Diagnostics INC. | $59.59 | 2021 | |
| Depuy Synthes Sales INC. | $50.66 | 2020 | |
| Integra Lifesciences Corporation | $49.23 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $39.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.92 | 2022-2023 | Gattex |
| Karl Storz Endoscopy-America | $24.42 | 2023 | |
| Abbvie INC. | $23.19 | 2025 | |
| Heron Therapeutics, INC. | $17.76 | 2021 | |
| Acacia Pharma INC | $17.05 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.